TACC3 and adenocarcinoma: The fusion of the fibroblast growth factor receptor 3 (FGFR3) to the transforming acidic coiled-coil 3 (TACC3) was observed independent of the tumor type (five squamous cell carcinomas and two adenocarcinomas) [23,24].